Skip to content

eMate - Intelligent online monitoring and support for chronic patients

eMate - Intelligent online monitoring and support for chronic patients - eMate

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON37933
Enrollment
340
Registered
2012-09-10
Start date
2012-08-13
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV and Diabetes Mellitus type II

Interventions

The intervention groups use the complete system (mobile phone app, website, electronic pillbox) and get tailored information
the control groups use the electronic pillboxes and get a link to general information about the importance of therapy adherence for their disease.

Sponsors

Vrije Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for diabetes patients are: 1) using oral antidiabetics >1 year; 2) using an Android-based smart phone; 3) using a personal computer with the Internet connection. Inclusion criteria for HIV-patients are: 1) using combination antiretroviral therapy for > 1 year; 2) using an Android-based smart phone; 3) using a personal computer with the Internet connection.

Exclusion criteria

Exclusion criteria: Exclusion criteria for both patients groups are: 1) age > 65 years; 2) age

Design outcomes

Primary

MeasureTime frame
Adherence to therapy 1) for medication as measured by the system (% of medication intakes taken) and 2) lifestyle aspects measured via questionnaires (number of gym visits, amount of physical activities and their intensity, healthy and unhealthy food consumption). The ultimate goal is that the system provides an improved adherence to therapy (both to medication intake and life style changes), eventually resulting in a reduction in the risk of developing late-stage complications.

Secondary

MeasureTime frame
N.A.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)